美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PELTHOS THERAPEUTICS INC

21.90

-0.5300-2.36%

盤後：21.900.00000.00%19:30 EDT

成交量：1.89萬

成交額：41.67萬

市值：8,384.42萬

市盈率：-0.83

高：23.12

開：22.62

低：21.21

收：22.43

52周最高：37.50

52周最低：18.19

股本：382.85萬

流通股本：106.55萬

量比：0.52

換手率：1.78%

股息：- -

股息率：- -

每股收益(TTM):-26.3603

每股收益(LYR):-23.0359

淨資產收益率：-333.84%

總資產收益率：-49.98%

市淨率：-55.86

市盈率(LYR):-0.95

資料載入中...

總覽公司新聞公告

Pelthos Therapeutics股價下跌，因該公司表示將重述第一季度財務報表

Pelthos Therapeutics 一季度財報不再可信——SEC文件披露

Pelthos Therapeutics財務重述：對2026年第一季度現金流與流動性無影響——SEC文件披露

Pelthos Therapeutics 在2026年3月31日SEC文件中揭示內部控制存在重大缺陷

Pelthos Therapeutics獲納入羅素3000E™成長基準指數、羅素微型股®及羅素微型股®成長基準指數

Pelthos Therapeutics宣佈首位患者接受Ct2000治療眼痛1B/2a期臨床試驗給藥

Pelthos Therapeutics公司：具備商業基礎設施與經驗，持續推動Zelsuvmi增長，併成功上市及拓展Xepi與Xeglyze

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/PTHS/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTHS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","market":"US","secType":"STK","nameCN":"PELTHOS THERAPEUTICS INC","latestPrice":21.9,"timestamp":1789156800000,"preClose":22.43,"halted":0,"volume":18947,"hourTrading":{"tag":"盘后","latestPrice":21.9,"preClose":21.9,"latestTime":"19:30 EDT","volume":16,"amount":350.04,"timestamp":1789169407503,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.023629068212215835,"floatShares":1065500,"shares":3828500,"eps":-26.360256,"marketStatus":"休市中","change":-0.53,"latestTime":"09-11 16:00:00 EDT","open":22.62,"high":23.12,"low":21.21,"amount":416712.92867,"amplitude":0.085154,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-26.360256,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1708059600000,"exchange":"AMEX","adjPreClose":22.43,"postHourTrading":{"tag":"盘后","latestPrice":21.9,"preClose":21.9,"latestTime":"19:30 EDT","volume":16,"amount":350.04,"timestamp":1789169407503,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5174739988768293},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","floatShares":1065500,"roa":"-49.98%","roe":"-333.84%","lyrEps":-23.035919,"volumeRatio":0.5174739988768293,"shares":3828500,"dividePrice":0,"high":23.12,"amplitude":0.085154,"preClose":22.43,"low":21.21,"week52Low":18.19,"pbRate":"-55.86","psRate":"1.94","week52High":37.5,"institutionHeld":0,"latestPrice":21.9,"eps":-26.360256,"divideRate":0,"volume":18947,"delay":0,"ttmEps":-26.360256,"open":22.62,"prevYearClose":31,"prevWeekClose":24.35,"prevMonthClose":24.08,"prevQuarterClose":28.26,"fiveDayClose":24.36,"twentyDayClose":28.95,"sixtyDayClose":28.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTHS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PTHS","fiscalQuarterEnding":"2026/06","expectedEps":-3.02,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-6.62},{"market":"US","date":"2026-05-14","symbol":"PTHS","fiscalQuarterEnding":"2026/03","expectedEps":4,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"pre","actualEps":-3.09},{"market":"US","date":"2026-03-19","symbol":"PTHS","fiscalQuarterEnding":"2025/12","expectedEps":-3.95,"name":null,"time":"盤前","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"pre","actualEps":-2.83},{"market":"US","date":"2025-11-13","symbol":"PTHS","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"盤前","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-5.3},{"market":"US","date":"2025-07-02","symbol":"PTHS","defaultRemindTime":1751463000000,"type":"split","dateTimestamp":1751428800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTHS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTHS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.8571,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1775102400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTHS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTHS","date":"2026-09-11","current":-0.830796,"percent":1,"low":-12.702408,"twenty":-3.928626,"median":-1.973761,"eighty":-1.751149,"high":-0.993987,"avg":-3.800131,"sd":3.317118,"marketCap":85872559},"quantilePoints":[{"date":"2025-07-03","current":-1.450338,"twenty":-1.398151,"median":-1.319871,"eighty":-1.241591,"marketCap":10675383},{"date":"2025-07-11","current":-2.372872,"twenty":-2.216593,"median":-1.475876,"eighty":-1.450338,"marketCap":17465810},{"date":"2025-07-18","current":-1.983069,"twenty":-1.968731,"median":-1.794665,"eighty":-1.455446,"marketCap":14596616},{"date":"2025-07-25","current":-1.97142,"twenty":-1.96909,"median":-1.819083,"eighty":-1.509032,"marketCap":14510870},{"date":"2025-08-01","current":-1.895251,"twenty":-1.972137,"median":-1.894355,"eighty":-1.668896,"marketCap":13950222},{"date":"2025-08-08","current":-1.785927,"twenty":-1.971241,"median":-1.88181,"eighty":-1.778579,"marketCap":13145529},{"date":"2025-08-15","current":-1.383693,"twenty":-1.968373,"median":-1.828044,"eighty":-1.653842,"marketCap":12505731},{"date":"2025-08-22","current":-1.565412,"twenty":-1.958336,"median":-1.793992,"eighty":-1.534031,"marketCap":14148098},{"date":"2025-08-29","current":-7.738365,"twenty":-1.968373,"median":-1.78996,"eighty":-1.553735,"marketCap":69938867},{"date":"2025-09-05","current":-10.936036,"twenty":-1.983069,"median":-1.813483,"eighty":-1.562493,"marketCap":98839226},{"date":"2025-09-12","current":-10.771103,"twenty":-7.559968,"median":-1.868816,"eighty":-1.565412,"marketCap":97348576},{"date":"2025-09-19","current":-11.212045,"twenty":-9.357396,"median":-1.887634,"eighty":-1.641655,"marketCap":101333783},{"date":"2025-09-26","current":-11.188484,"twenty":-10.771103,"median":-1.911381,"eighty":-1.642041,"marketCap":101120833},{"date":"2025-10-03","current":-8.961188,"twenty":-10.771103,"median":-1.965147,"eighty":-1.648609,"marketCap":80990668},{"date":"2025-10-10","current":-8.414925,"twenty":-10.626367,"median":-1.972316,"eighty":-1.659169,"marketCap":76053575},{"date":"2025-10-17","current":-9.593014,"twenty":-10.434506,"median":-2.154672,"eighty":-1.70259,"marketCap":86701075},{"date":"2025-10-24","current":-11.663085,"twenty":-10.626367,"median":-7.559968,"eighty":-1.70259,"marketCap":105410254},{"date":"2025-10-31","current":-11.19185,"twenty":-10.777835,"median":-7.80905,"eighty":-1.706174,"marketCap":101151254},{"date":"2025-11-07","current":-12.702408,"twenty":-10.936036,"median":-7.98408,"eighty":-1.777862,"marketCap":114803587},{"date":"2025-11-14","current":-11.772301,"twenty":-11.111066,"median":-8.995487,"eighty":-1.781447,"marketCap":106397338},{"date":"2025-11-21","current":-3.765213,"twenty":-11.111066,"median":-8.414925,"eighty":-1.785927,"marketCap":88788749},{"date":"2025-11-28","current":-3.687312,"twenty":-11.108373,"median":-7.960687,"eighty":-1.792379,"marketCap":86951740},{"date":"2025-12-05","current":-3.422448,"twenty":-11.024224,"median":-7.763609,"eighty":-1.805104,"marketCap":80705911},{"date":"2025-12-12","current":-3.133628,"twenty":-10.952193,"median":-4.332389,"eighty":-1.816843,"marketCap":73895143},{"date":"2025-12-19","current":-2.967391,"twenty":-10.936709,"median":-3.83078,"eighty":-1.833421,"marketCap":69975058},{"date":"2025-12-26","current":-3.468719,"twenty":-10.936036,"median":-3.687312,"eighty":-1.856092,"marketCap":81797046},{"date":"2026-01-02","current":-4.057747,"twenty":-10.93065,"median":-3.642809,"eighty":-1.874014,"marketCap":95687111},{"date":"2026-01-09","current":-3.672916,"twenty":-10.883527,"median":-3.665062,"eighty":-1.88181,"marketCap":86612268},{"date":"2026-01-16","current":-3.395418,"twenty":-10.806109,"median":-3.583058,"eighty":-1.88647,"marketCap":80068505},{"date":"2026-01-23","current":-3.187295,"twenty":-10.776489,"median":-3.555764,"eighty":-1.893817,"marketCap":75160682},{"date":"2026-01-30","current":-3.374475,"twenty":-10.771103,"median":-3.506679,"eighty":-1.898477,"marketCap":79574636},{"date":"2026-02-06","current":-3.052604,"twenty":-10.742156,"median":-3.468719,"eighty":-1.919625,"marketCap":71984487},{"date":"2026-02-13","current":-2.833747,"twenty":-10.623674,"median":-3.435432,"eighty":-1.954036,"marketCap":66823556},{"date":"2026-02-20","current":-3.036408,"twenty":-10.612903,"median":-3.401675,"eighty":-1.95977,"marketCap":71602566},{"date":"2026-02-27","current":-3.155779,"twenty":-10.602805,"median":-3.390837,"eighty":-1.970524,"marketCap":74417489},{"date":"2026-03-06","current":-3.074826,"twenty":-10.434506,"median":-3.374475,"eighty":-1.97142,"marketCap":72508518},{"date":"2026-03-13","current":-3.190081,"twenty":-10.434506,"median":-3.360076,"eighty":-1.972316,"marketCap":75226374},{"date":"2026-03-20","current":-1.7154,"twenty":-10.097909,"median":-3.349516,"eighty":-1.97142,"marketCap":74309421},{"date":"2026-03-27","current":-1.761468,"twenty":-9.761313,"median":-3.316998,"eighty":-1.911381,"marketCap":76305047},{"date":"2026-04-02","current":-1.649924,"twenty":-9.626674,"median":-3.312954,"eighty":-1.88181,"marketCap":71473065},{"date":"2026-04-10","current":-1.749075,"twenty":-9.525695,"median":-3.297807,"eighty":-1.833421,"marketCap":75768160},{"date":"2026-04-17","current":-1.781608,"twenty":-9.500787,"median":-3.280885,"eighty":-1.792379,"marketCap":77177489},{"date":"2026-04-24","current":-1.797101,"twenty":-9.439526,"median":-3.26405,"eighty":-1.781608,"marketCap":77848597},{"date":"2026-05-01","current":-1.936531,"twenty":-9.424716,"median":-3.220673,"eighty":-1.782538,"marketCap":83888575},{"date":"2026-05-08","current":-1.938855,"twenty":-9.37086,"median":-3.190081,"eighty":-1.785296,"marketCap":83989241},{"date":"2026-05-15","current":-2.144901,"twenty":-9.354703,"median":-3.188002,"eighty":-1.78619,"marketCap":92914985},{"date":"2026-05-22","current":-1.825776,"twenty":-9.310946,"median":-3.162639,"eighty":-1.782538,"marketCap":94189979},{"date":"2026-05-29","current":-1.738193,"twenty":-9.201215,"median":-3.155779,"eighty":-1.782305,"marketCap":89671641},{"date":"2026-06-05","current":-1.742235,"twenty":-9.106968,"median":-3.138864,"eighty":-1.781608,"marketCap":89880179},{"date":"2026-06-12","current":-1.934919,"twenty":-9.053119,"median":-3.057709,"eighty":-1.781608,"marketCap":99820524},{"date":"2026-06-18","current":-1.819713,"twenty":-9.002347,"median":-3.051164,"eighty":-1.781608,"marketCap":93877171},{"date":"2026-06-26","current":-1.967931,"twenty":-8.742683,"median":-3.016477,"eighty":-1.781608,"marketCap":101523590},{"date":"2026-07-02","current":-1.886411,"twenty":-8.328756,"median":-3.009278,"eighty":-1.781608,"marketCap":97318060},{"date":"2026-07-10","current":-1.829819,"twenty":-7.979401,"median":-2.945794,"eighty":-1.781608,"marketCap":94398518},{"date":"2026-07-17","current":-1.799501,"twenty":-7.934399,"median":-2.91896,"eighty":-1.781608,"marketCap":92834477},{"date":"2026-07-24","current":-1.91336,"twenty":-7.821168,"median":-2.887545,"eighty":-1.781608,"marketCap":98708318},{"date":"2026-07-31","current":-1.76851,"twenty":-7.788854,"median":-2.833747,"eighty":-1.781608,"marketCap":91235681},{"date":"2026-08-07","current":-1.9841,"twenty":-7.738365,"median":-2.592541,"eighty":-1.781608,"marketCap":102357745},{"date":"2026-08-14","current":-1.950414,"twenty":-7.559968,"median":-2.325379,"eighty":-1.781608,"marketCap":100619922},{"date":"2026-08-21","current":-1.18144,"twenty":-4.332389,"median":-2.094939,"eighty":-1.781447,"marketCap":102066983},{"date":"2026-08-28","current":-1.107877,"twenty":-4.131996,"median":-1.987469,"eighty":-1.771879,"marketCap":95711725},{"date":"2026-09-04","current":-1.079516,"twenty":-4.057747,"median":-1.983517,"eighty":-1.761468,"marketCap":93261504},{"date":"2026-09-11","current":-0.993987,"twenty":-3.928626,"median":-1.973761,"eighty":-1.751149,"marketCap":85872559}],"updateTime":1789317781256},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTHS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659655671","title":"Pelthos Therapeutics股價下跌，因該公司表示將重述第一季度財務報表","url":"https://stock-news.laohu8.com/highlight/detail?id=2659655671","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659655671?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 23:19","pubTimestamp":1786634351,"startTime":"0","endTime":"0","summary":"BUZZ-Pelthos Therapeutics股价下跌，因该公司表示将重述第一季度财务报表8月13日-** 佩尔索斯治疗公司（PTHS.A）股价在早盘交易中下跌1.8%，报28.41美元** Pelthos表示，已发现可转换债券估值方面的内部控制存在重大缺陷，并计划修订其第一季度报告** Pelthos Therapeutics表示，在发现部分可转换债券估值有误后，将重述其第一季度财务业绩**","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4S44A1CI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194177202","title":"Pelthos Therapeutics 一季度財報不再可信——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1194177202","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194177202?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 19:05","pubTimestamp":1786619148,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics 公司近日向美国证券交易委员会（SEC）提交文件称，截至3月31日的第一季度财务报表，已不再值得依赖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171481723","title":"Pelthos Therapeutics財務重述：對2026年第一季度現金流與流動性無影響——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1171481723","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171481723?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 19:05","pubTimestamp":1786619125,"startTime":"0","endTime":"0","summary":"根据彭洛斯治疗公司向美国证券交易委员会提交的最新文件，该公司明确指出，其财务重述不会对截至2026年3月31日的第一季度流动性或现金头寸产生任何影响。这一声明旨在澄清市场疑虑，并强调公司财务状况的稳健性。SEC文件进一步证实，该重述仅限于特定会计科目，并未牵涉到实际的现金流变动或银行账户余额的减少。因此，公司预计在接下来的报告期内，其整体财务健康度将继续保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128219395","title":"Pelthos Therapeutics 在2026年3月31日SEC文件中揭示內部控制存在重大缺陷","url":"https://stock-news.laohu8.com/highlight/detail?id=1128219395","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128219395?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 19:05","pubTimestamp":1786619122,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics 在其提交给美国证券交易委员会（SEC）的文件中明确指出，截至2026年3月31日，公司内部控制出现了一项重大弱点。这项披露标志着公司在财务报告管控层面遭遇了严峻挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110219751","title":"Pelthos Therapeutics獲納入羅素3000E™成長基準指數、羅素微型股®及羅素微型股®成長基準指數","url":"https://stock-news.laohu8.com/highlight/detail?id=1110219751","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110219751?lang=zh_tw&edition=fundamental","pubTime":"2026-07-01 04:29","pubTimestamp":1782851383,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics Inc. 已获纳入多项罗素指数，包括罗素3000E™成长基准指数、罗素微型股®指数以及罗素微型股®成长基准指数。这一纳入标志着该公司在资本市场的能见度与认可度得到显著提升，通常意味着其股票将吸引更多机构投资者的关注与资金配置。指数调整往往能带来流动性改善，并可能对股价产生积极影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158850215","title":"Pelthos Therapeutics宣佈首位患者接受Ct2000治療眼痛1B/2a期臨床試驗給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1158850215","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158850215?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 20:33","pubTimestamp":1774960393,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics公司已宣布，其用于治疗眼痛的在研药物Ct2000，在1B/2a期临床试验中完成了对首位患者的给药。这一进展标志着该候选药物的临床开发进入了新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104105143","title":"Pelthos Therapeutics公司：具備商業基礎設施與經驗，持續推動Zelsuvmi增長，併成功上市及拓展Xepi與Xeglyze","url":"https://stock-news.laohu8.com/highlight/detail?id=1104105143","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104105143?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 18:35","pubTimestamp":1773916543,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics公司凭借其成熟的商业基础设施与丰富的行业经验，已做好充分准备。公司不仅致力于持续推动其产品Zelsuvmi的市场增长，更将着眼于成功上市并进一步拓展Xepi与Xeglyze的商业版图。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}